Brian Skorney analyst BAIRD

Currently out of the existing stock ratings of Brian Skorney, 201 are a BUY (71.02%), 73 are a HOLD (25.8%), 9 are a SELL (3.18%).

Brian Skorney

Work Performance Price Targets & Ratings Chart

Analyst Brian Skorney works at BAIRD with a stock forecast success ratio of 64.72% fulfilled within 264.35 days on average.

Brian Skorney’s has documented 582 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 29-Feb-2024.

Wall Street Analyst Brian Skorney

Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 1/8/2020. The price target of $43 was fulfilled within 1 day with a profit of $7.82 (22.23%) receiving and performance score of 222.29.

Average potential price target upside

ACHN Achillion Pharmaceuticals AIMT Aimmune Therapeutics ALBO Albireo Pharma AMGN Amgen AXON Axon Enterprise . BIIB Biogen CELG Celgene CRIS Curis ENTA Enanta Pharmaceuticals GILD Gilead Sciences ICPT Intercept Pharmaceuticals MYOV Myovant Sciences Ltd NBIX Neurocrine Biosciences PRNB Principia Biopharma REGN Regeneron Pharmaceuticals RETA Reata Pharmaceuticals SRPT Sarepta Therapeutics TBPH Theravance Biopharma VRTX Vertex Pharmaceuticals VTGN VistaGen Therapeutics IMVT Immunovant  PTI Proteostasis Therapeutics TTPH Tetraphase Pharmaceuticals VYGR Voyager Therapeutics RPHM Reneo Pharmaceuticals MRNS Marinus Pharmaceuticals APLT Applied Therapeutics CRNX Crinetics Pharmaceuticals INVA Innoviva MIRM Mirum Pharmaceuticals EIGR Eiger Biopharmaceuticals RGNX Regenxbio

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$1.82 (1011.11%)


4 years 11 months 9 days ago

2/3 (66.67%)

$-0.96 (-32.43%)




6 years 2 months 4 days ago

4/4 (100%)

$-0.81 (-16.84%)




$4.82 (2677.78%)


6 years 4 months 1 days ago

0/4 (0%)

$2.14 (74.83%)



6 years 7 months ago

0/2 (0%)

$5.79 (137.53%)



$3.82 (2122.22%)


6 years 7 months 1 days ago

6/7 (85.71%)

$0.17 (4.44%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Brian Skorney is most bullish on?

Potential upside of $111.05 has been obtained for BIIB (BIOGEN)

Which stock is Brian Skorney is most reserved on?

Potential downside of -$141.48 has been obtained for REGN (REGENERON PHARMACEUTICALS)

What Year was the first public recommendation made by Brian Skorney?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?